Back to Search
PAOLA GEHRIG, MD
MD
Gynecologic Oncology Physician
NPI: 1972691376IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
9700678(NC)0101275130(VA)
Education
UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Class of 1993
Research & Publications (20)
Changes in the proteome after neuronal zif268 overexpression.
PMID 19374395·J Proteome Res·2009
7-preclinical
Identification of apolipoprotein N-acyltransferase (Lnt) in mycobacteria.
PMID 19661058·J Biol Chem·2009
8-other
Phosphorylated serine and threonine residues promote site-specific fragmentation of singly charged, arginine-containing peptide ions.
PMID 19353557·Rapid Commun Mass Spectrom·2009
8-other
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
PMID 19560193·Gynecol Oncol·2009
4-observational
Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
PMID 19446319·Gynecol Oncol·2009
4-observational
Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review.
PMID 19592079·Gynecol Oncol·2009
6-review
Quantitative detection of changes in the leaf-mesophyll tonoplast proteome in dependency of a cadmium exposure of barley (Hordeum vulgare L.) plants.
PMID 19391183·Proteomics·2009
8-other
Proteomic profiling of Cronobacter turicensis 3032, a food-borne opportunistic pathogen.
PMID 19609963·Proteomics·2009
8-other
Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
PMID 19484784·Cancer·2009
8-other
Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma.
PMID 19306417·Cancer·2009
4-observational
Neuronal Nogo-A modulates growth cone motility via Rho-GTP/LIMK1/cofilin in the unlesioned adult nervous system.
PMID 19208621·J Biol Chem·2009
7-preclinical
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.
PMID 19118888·Gynecol Oncol·2009
4-observational
An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease.
PMID 19089850·J Pathol·2009
8-other
Attitudes regarding the use of hematopoietic colony-stimulating factors and maintenance of relative dose intensity among gynecologic oncologists.
PMID 19407573·Int J Gynecol Cancer·2009
8-other
Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes.
PMID 19078929·Cancer Control·2009
6-review
Intersubunit cross-talk in pyridoxal 5'-phosphate synthase, coordinated by the C terminus of the synthase subunit.
PMID 19074821·J Biol Chem·2009
8-other
What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?
PMID 18694588·Gynecol Oncol·2008
8-other
A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy.
PMID 18928973·Am J Obstet Gynecol·2008
4-observational
A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy.
PMID 18928974·Am J Obstet Gynecol·2008
4-observational
Arsenic trioxide (As2O3) inhibits expression of estrogen receptor-alpha through regulation of the mitogen-activated protein kinase (MAPK) pathway in endometrial cancer cells.
PMID 19088370·Reprod Sci·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 4 locations total
- Address
- 1240 LEE ST
CHARLOTTESVILLE, VA 22908 - Phone
- (434) 924-9333
Quick Facts
- NPI
- 1972691376
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 4
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile